Matches in Nanopublications for { ?s ?p "[In vivo, ALK regulated VEGFA production and tumor angiogenesis in ALCL and NSCLC, and the treatment with the anti-VEGFA antibody bevacizumab strongly impaired ALCL growth in mouse xenografts.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 11 of
11
with 100 items per page.
- assertion description "[In vivo, ALK regulated VEGFA production and tumor angiogenesis in ALCL and NSCLC, and the treatment with the anti-VEGFA antibody bevacizumab strongly impaired ALCL growth in mouse xenografts.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP770002.RAVrmWwAwYTAc1waQ6hpdpFkl17GZaCRjnp1aavstIrFE130_assertion description "[In vivo, ALK regulated VEGFA production and tumor angiogenesis in ALCL and NSCLC, and the treatment with the anti-VEGFA antibody bevacizumab strongly impaired ALCL growth in mouse xenografts.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP770002.RAVrmWwAwYTAc1waQ6hpdpFkl17GZaCRjnp1aavstIrFE130_provenance.
- NP771477.RAXNBau7fj8b9Gj8Ow8BphkOtkXPESaOBFSdztF2xg4SY130_assertion description "[In vivo, ALK regulated VEGFA production and tumor angiogenesis in ALCL and NSCLC, and the treatment with the anti-VEGFA antibody bevacizumab strongly impaired ALCL growth in mouse xenografts.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP771477.RAXNBau7fj8b9Gj8Ow8BphkOtkXPESaOBFSdztF2xg4SY130_provenance.
- NP772646.RAU0mYwhINrDQb-S9cFVcFdZ6BaHRWsE87_ImnJGn6lvs130_assertion description "[In vivo, ALK regulated VEGFA production and tumor angiogenesis in ALCL and NSCLC, and the treatment with the anti-VEGFA antibody bevacizumab strongly impaired ALCL growth in mouse xenografts.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP772646.RAU0mYwhINrDQb-S9cFVcFdZ6BaHRWsE87_ImnJGn6lvs130_provenance.
- assertion description "[In vivo, ALK regulated VEGFA production and tumor angiogenesis in ALCL and NSCLC, and the treatment with the anti-VEGFA antibody bevacizumab strongly impaired ALCL growth in mouse xenografts.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[In vivo, ALK regulated VEGFA production and tumor angiogenesis in ALCL and NSCLC, and the treatment with the anti-VEGFA antibody bevacizumab strongly impaired ALCL growth in mouse xenografts.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP235845.RAmgD2I37z7GM0tuiWWLnvt6Z4aQcZ2R2kBxYxqh2ioDM130_assertion description "[In vivo, ALK regulated VEGFA production and tumor angiogenesis in ALCL and NSCLC, and the treatment with the anti-VEGFA antibody bevacizumab strongly impaired ALCL growth in mouse xenografts.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP235845.RAmgD2I37z7GM0tuiWWLnvt6Z4aQcZ2R2kBxYxqh2ioDM130_provenance.
- NP1217382.RAWqD3vH-4otJVabVOCxwkRyGnwzhAI7TCwjTulQz7Dbw130_assertion description "[In vivo, ALK regulated VEGFA production and tumor angiogenesis in ALCL and NSCLC, and the treatment with the anti-VEGFA antibody bevacizumab strongly impaired ALCL growth in mouse xenografts.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1217382.RAWqD3vH-4otJVabVOCxwkRyGnwzhAI7TCwjTulQz7Dbw130_provenance.
- NP1217385.RAdLzQh-TR_vWulFWBgLLD20RyF10hVEppWn9RzD1Tscs130_assertion description "[In vivo, ALK regulated VEGFA production and tumor angiogenesis in ALCL and NSCLC, and the treatment with the anti-VEGFA antibody bevacizumab strongly impaired ALCL growth in mouse xenografts.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1217385.RAdLzQh-TR_vWulFWBgLLD20RyF10hVEppWn9RzD1Tscs130_provenance.
- NP1217383.RAFpfwsnSGRVrXcVEEhEjtX3be6u8TtZrixKC_nUoikV4130_assertion description "[In vivo, ALK regulated VEGFA production and tumor angiogenesis in ALCL and NSCLC, and the treatment with the anti-VEGFA antibody bevacizumab strongly impaired ALCL growth in mouse xenografts.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1217383.RAFpfwsnSGRVrXcVEEhEjtX3be6u8TtZrixKC_nUoikV4130_provenance.
- NP1217384.RA2gup5DgOq60_4cDA1t-KPn81K83btR-iFv4d_rnvx5Y130_assertion description "[In vivo, ALK regulated VEGFA production and tumor angiogenesis in ALCL and NSCLC, and the treatment with the anti-VEGFA antibody bevacizumab strongly impaired ALCL growth in mouse xenografts.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1217384.RA2gup5DgOq60_4cDA1t-KPn81K83btR-iFv4d_rnvx5Y130_provenance.